These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25483503)

  • 41. Parental intent to initiate and complete the human papillomavirus vaccine series in the USA: a nationwide, cross-sectional survey.
    Sonawane K; Zhu Y; Montealegre JR; Lairson DR; Bauer C; McGee LU; Giuliano AR; Deshmukh AA
    Lancet Public Health; 2020 Sep; 5(9):e484-e492. PubMed ID: 32707126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adolescent Vaccines: Latest Recommendations, Addressing Barriers, and Improving Vaccine Rates.
    Rose KC
    NASN Sch Nurse; 2017 Jul; 32(4):217-222. PubMed ID: 28557635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors that influence parental vaccination decisions for adolescents, 13 to 17 years old: National Immunization Survey-Teen, 2010.
    Dorell C; Yankey D; Kennedy A; Stokley S
    Clin Pediatr (Phila); 2013 Feb; 52(2):162-70. PubMed ID: 23221308
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.
    Kretsinger K; Broder KR; Cortese MM; Joyce MP; Ortega-Sanchez I; Lee GM; Tiwari T; Cohn AC; Slade BA; Iskander JK; Mijalski CM; Brown KH; Murphy TV; ; ;
    MMWR Recomm Rep; 2006 Dec; 55(RR-17):1-37. PubMed ID: 17167397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized study.
    Rivera L; Schwarz TF; Kim KH; Kim YK; Behre U; Cha SH; Jo DS; Lee J; Lee JS; Cheuvart B; Jastorff A; Van der Wielen M
    Vaccine; 2018 Jul; 36(31):4750-4758. PubMed ID: 29960800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Achieving High Adolescent HPV Vaccination Coverage.
    Farmar AM; Love-Osborne K; Chichester K; Breslin K; Bronkan K; Hambidge SJ
    Pediatrics; 2016 Nov; 138(5):. PubMed ID: 27940751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Physician communication about adolescent vaccination: How is human papillomavirus vaccine different?
    Gilkey MB; Moss JL; Coyne-Beasley T; Hall ME; Shah PD; Brewer NT
    Prev Med; 2015 Aug; 77():181-5. PubMed ID: 26051197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Missed Vaccination Opportunities Among U.S. Adolescents by Area Characteristics.
    Pruitt SL; Tiro JA; Kepka D; Henry K
    Am J Prev Med; 2022 Apr; 62(4):538-547. PubMed ID: 35125272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gender of the Clinician, Child, and Guardian and the Association With Receipt of Routine Adolescent Vaccines.
    Faherty LJ; French B; Fiks AG
    J Adolesc Health; 2016 Jul; 59(1):116-22. PubMed ID: 27188630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccine-related attitudes and decision-making among uninsured, Latin American immigrant mothers of adolescent daughters: a qualitative study.
    Painter JE; Viana De O Mesquita S; Jimenez L; Avila AA; Sutter CJ; Sutter R
    Hum Vaccin Immunother; 2019; 15(1):121-133. PubMed ID: 30199302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Using the 4 Pillars™ Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination.
    Zimmerman RK; Raviotta JM; Nowalk MP; Moehling KK; Reis EC; Humiston SG; Lin CJ
    Vaccine; 2017 Oct; 35(45):6180-6186. PubMed ID: 28947346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines.
    Arguedas A; Soley C; Loaiza C; Rincon G; Guevara S; Perez A; Porras W; Alvarado O; Aguilar L; Abdelnour A; Grunwald U; Bedell L; Anemona A; Dull PM
    Vaccine; 2010 Apr; 28(18):3171-9. PubMed ID: 20189491
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine use in wound management on health care costs and pertussis cases.
    Talbird SE; Graham J; Mauskopf J; Masseria C; Krishnarajah G
    J Manag Care Spec Pharm; 2015 Jan; 21(1):88-99, 99a-c. PubMed ID: 25562776
    [TBL] [Abstract][Full Text] [Related]  

  • 54. National and State-Level Composite Completion of Recommended Vaccines Among Adolescents in the United States, 2015-2018.
    La EM; Garbinsky D; Hunter S; Poston S; Novy P; Ghaswalla P
    J Adolesc Health; 2021 Nov; 69(5):762-768. PubMed ID: 34518068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors associated with human papillomavirus and meningococcal vaccination among adolescents living in rural and urban areas.
    Boyce TG; Christianson B; Hanson KE; Dunn D; Polter E; VanWormer JJ; Williams CL; Belongia EA; McLean HQ
    Vaccine X; 2022 Aug; 11():100180. PubMed ID: 35755142
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simple and Elaborated Clinician Reminder Prompts for Human Papillomavirus Vaccination: A Randomized Clinical Trial.
    Zimet G; Dixon BE; Xiao S; Tu W; Kulkarni A; Dugan T; Sheley M; Downs SM
    Acad Pediatr; 2018 Mar; 18(2S):S66-S71. PubMed ID: 29502640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recommendations for Structure and Content for a School-Based Adolescent Immunization Curriculum.
    Salazar KR; Seib KG; Underwood NL; Gargano LM; Sales JM; Morfaw C; Murray D; Diclemente RJ; Hughes JM
    Health Promot Pract; 2016 Jul; 17(4):512-20. PubMed ID: 27009129
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New adolescent vaccination recommendations and how to make them "stick".
    Middleman AB
    Curr Opin Pediatr; 2007 Aug; 19(4):411-6. PubMed ID: 17630604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Provider communication and HPV vaccination: The impact of recommendation quality.
    Gilkey MB; Calo WA; Moss JL; Shah PD; Marciniak MW; Brewer NT
    Vaccine; 2016 Feb; 34(9):1187-92. PubMed ID: 26812078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adolescent vaccinations: updates for the general practitioner.
    Mealey K; Koenigs LMP
    Curr Opin Pediatr; 2019 Aug; 31(4):442-447. PubMed ID: 30939514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.